Skip to main content

Supplementary Figure 4 from Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism

Publication ,  Other
Wu, X; Adame-Garcia, SR; Koshizuka, K; Vo, PTT; Hoang, TS; Sato, K; Izumi, H; Goto, Y; Allevato, MM; Wood, KC; Lippman, SM; Gutkind, JS
December 3, 2024

<p>Supplementary Figure 4: Synergistic effects of Metformin and Dichloroacetate (DCA) in HNSCC cell lines</p>

Duke Scholars

DOI

Publication Date

December 3, 2024
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wu, X., Adame-Garcia, S. R., Koshizuka, K., Vo, P. T. T., Hoang, T. S., Sato, K., … Gutkind, J. S. (2024). Supplementary Figure 4 from Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism. https://doi.org/10.1158/1940-6207.27951076
Wu, Xingyu, Sendi Rafael Adame-Garcia, Keiichi Koshizuka, Pham Thuy Tien Vo, Thomas S. Hoang, Kuniaki Sato, Hiroki Izumi, et al. “Supplementary Figure 4 from Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism,” December 3, 2024. https://doi.org/10.1158/1940-6207.27951076.
Wu X, Adame-Garcia SR, Koshizuka K, Vo PTT, Hoang TS, Sato K, Izumi H, Goto Y, Allevato MM, Wood KC, Lippman SM, Gutkind JS. Supplementary Figure 4 from Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism. 2024.

DOI

Publication Date

December 3, 2024